Procrit

Epoetin alfa

Epoetin
Epoetin alfa is human erythropoietin produced in cell culture using recombinant DNA technology. It stimulates erythropoiesis and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen. Its annual cost to U.S. patients is $8,447

Procrit - List of case studies

MDS – Myelodysplastic Syndrome

symptomatic anemia supervenes, erythopoietin injections (Procrit, Aranesp, Epogen) may help support the red blood cells . Sometimes ... Medicines : alpha blocker, chemotherapy, erythropoietin, Procrit, Aranesp, Epogen, G-CSF, Neupogen, lenalidomide, Revlimid, Vidaza, ...

Drugs

Erbitux Erlotinib Erythopoietin injections (Procrit Erythropoeitin Erythropoetin Erythropoietin ... Pregabalin Pregabaline Pregnal Procrit Progestin Progestogens Prontogest Propofenac ...

Myelodysplastic syndrome (MDS), with kariotype del(11)q(11)

anemia supervenes, erythopoietin injections ( Procrit, Aranesp, Epogen ) may help support the red blood cells. Sometimes ... erythopoietin injections (Procrit, Aranesp, Epogen), G-CSF (Neupogen), lenalidomide (Revlimid), Vidaza, ...

JustAnswer.com